$DHTI · Dalrada Technology Group, Inc.
Dalrada Technology Group filed an 8-K reporting a Settlement Agreement with IBS Equity Fund III and IBS Private Credit Fund IV, resolving a dispute over approximately $1,162,246 in demanded fees and charges. Dalrada paid a single $20,000 lump sum, and in exchange all Financing Documents were terminated, the secured promissory note cancelled, the pre-funded warrant extinguished, all guaranties released, and all liens and security interests over company assets discharged. IBS confirmed it holds no equity or purchase rights in Dalrada.
- IBS demanded ~$1,162,246 in fees and charges under the Financing Documents, which Dalrada disputed.
- Dalrada paid a single lump-sum settlement of $20,000 to fully resolve all claims.
- All Financing Documents terminated: MGA, MCSPA, promissory note, pre-funded warrant, and guaranties extinguished.
- IBS confirmed it holds no shares, warrants, options, or equity rights in Dalrada or any subsidiary.
- All liens, security interests, pledges, and account-control rights over Dalrada's assets were released.
Price data unavailable.
A micro-cap facing a $1.16M default claim and potential lien enforcement settled for pocket change with zero dilution — a rare outcome that removes existential balance-sheet risk.
Micro-cap companies facing aggressive lender default notices often see equity wiped out via lien enforcement or dilution from warrant exercises; Dalrada extinguished both risks for $20,000.
The Settlement Agreement contains mutual non-disparagement and confidentiality provisions; any breach could revive disputes. Post-closing obligations (bank release notices, return of instruments) remain subject to counterparty performance risk.
Get filings like this before the market reacts.
Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.